NMMC Announces First Patient Treated with Tryton Side Branch Stent
TUPELO, Miss.— Interventional cardiologists at North Mississippi Medical Center recently completed their first case using a novel stent to treat blockages that involve branches of blood vessels.
Coronary artery disease, the leading cause of death in the U.S. in both men and women, often results from buildup of plaque at a site where one artery branches from another, also known as a bifurcation. Approximately 20-30 percent of all patients undergoing percutaneous coronary interventions to open blocked arteries have a severe bifurcation lesion.
In the past, the majority of these lesions required bypass surgery, but now a new option exists. The Cordis Tryton Side Branch Stent was implanted by Barry Bertolet, M.D. in a patient with a bifurcation lesion who was not a candidate for surgery. Tryton is made from cobalt chromium engineered to provide an ideal, strong scaffolding for blocked arteries and more predictable patient outcomes than other present-day options.